Salt of the earth or a drop in the ocean? A pathophysiological approach to fluid resuscitation

Emergency Medicine Journal

Volumn 20, Issue 4, 2003, Pages 306-315

  Gosling, Peter ^a  

^a SELLY OAK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DIURETIC AGENT; ELECTROLYTE; GLUCOSE; HARTMANN SOLUTION; HETASTARCH; HYPERTONIC SOLUTION; INFUSION FLUID; PLASMA PROTEIN; RINGER LACTATE SOLUTION; SODIUM; SODIUM CHLORIDE; WATER;

BLOOD VESSEL PERMEABILITY; CAPILLARY LEAK SYNDROME; CIRCULATION; CLINICAL TRIAL; COLLOID; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DISEASE SEVERITY; DRUG COST; EDEMA; ELECTROLYTE METABOLISM; ENDOCRINE SYSTEM; ERYTHROCYTE TRANSFUSION; FLUID BALANCE; FLUID THERAPY; HEART STROKE VOLUME; HEMODYNAMIC MONITORING; HORMONE RESPONSE; HUMAN; HYPERCHLOREMIC ACIDOSIS; HYPONATREMIA; HYPOVOLEMIA; HYPOVOLEMIC SHOCK; INJURY; INTERSTITIAL FLUID; LUNG WEDGE PRESSURE; MALNUTRITION; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME; REVIEW; SALT LOADING; SODIUM BALANCE; SODIUM LOAD; SODIUM RETENTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TISSUE OXYGENATION; WATER RETENTION; WEIGHT GAIN;

EID: 0037961183     PISSN: 13510622     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.20.4.306     Document Type: Review

References (74)

1. Cochrane Inquries Group Albumin Reviewers. Human albumin administration in critically ill patients: Systematic review of randomised controlled trials. BMJ 1998;317:235-40.
2. See correspondence. Fluid resuscitation with colloid or crystalloid. BMJ 1998;317:277-9.
3. Tietz N W, ed. Clinical Guide to Laboratory Tests. 3rd edn. Philadelphia: W B Saunders, 1995.
4. Stoneham MD, Hill EL. Variability in post-operative fluid and electrolyte prescribing. Br J Clin Pract 1977;51:82-4.
5. Bowyer MW. Fluid therapy. In: Parsons PE, Wiener-Kronish JP, eds. Critical Care Secrets. St Louis: Mosby-Year Book, 1998: 26.
6. Flear CT, Singh CM. Hyponatraemia and sick cells. Br J Anaesth 1973;45:976-94.
7. Cunningham JN, Shires GT, Wagner Y. Changes in intracellular sodium and potassium content of red blood cells in trauma and shock. Am J Surg 1971;122:650-4.
8. Brown GC. Nitric oxide as a competitive inhibitor of oxygen consumption in the mitochondrial respiratory chain. Acta Physiol Scand 2000;168:667-74.
9. Hannon RJ, Boston VE. Fluid and ion redistribution in skeletal muscle in an animal sepsis model. J Pediatr Surg 1990;25:599-603.
10. Fleck A, Raines G, Hawker F, et al. Increased vascular permeability; A major cause of hypoalbuminaemia in disease and injury. Lancet 1985;i:781-3.
11. Zikria BA, Bascom JU. Mechanisms of multiple organ failure. In: Zikria BA, Oz MC, Carlson RW, eds. Reperfusion Injuries and Clinical Capillary Leak Syndrome. Armonk, NY: Futura, 1994:443-92.
12. McDonald DM, Thurston G, Baluk P. Endothelial gaps as sites for plasma leakage in inflammation. Microcirculation 1999;6:7-22.
13. Gosling P. Albumin: Friend or foe? Trauma 2000;2:125-34.
14. Stone HH, Fulenwider JT. Renal decapsulation in the prevention of post ischaemia oliguria. Ann Surg 1977;186:343-55.
15. Davies MG, Hagen PO. Systemic inflammatory response syndrome. Br J Surg 1997;84:920-35.
16. Pallister I, Gosling P, Alpar K, et al. Prediction of post traumatic adult respiratory distress syndrome by albumin excretion rate eight hours after admission. J Trauma 1997;42:1056-61.
17. Smith CT, Gosling P, Sanghera K, et al. Microproteinuria predicts the severity of systemic effects of reperfusion injury following infra renal aortic aneurysm surgery. Ann Vasc Surg 1994;8:1-5.
18. Gosling P, Hughes EA, Reynolds TM, et al. Microalbuminuria is an early response following acute myocardial infarction. Eur Heart J 1991;12:508-13.
19. MacKinnon KL, Molnar Z, Lowe D, et al. Use of microalbuminuria as a predictor of outcome in critically ill patients. Br J Anaesth 2000;84:239-41.
20. Adid O, Sun Q, Sugimoto K, et al. Predictive value of microalbuminuria in medical ICU patients: Results of a pilot study. Chest 2001;120:1984-8.
21. Gosling P, Brudney S, McGrath L, et al. Mortality prediction on admission to intensive care: A comparison of microalbuminuria with acute physiology scores after 24 hours. Crit Care Med 2003;31:98-103.
22. Wilkinson AW, Billing BH, Nagy G, et al. Excretion of chloride and sodium after surgical operations. Lancet 1949;i:640-4.
23. Moore FD. Metabolic Care of the Surgical Patient. Philadelphia: W B Saunders, 1959.
24. Frye RL. Chronic congestive heart failure. Eight steps in management. Postgrad Med 1981;69:165-169.
25. Yu AS, Hu KQ Management of ascites. Clin Liver Dis 2001;5:541-68 i.
26. Arieff AI. Fatal postoperative pulmonary oedema: Pathogenesis and literature review. Chest 1999;115:1371-7.
27. Lobo DN, Stanga Z, Simpson JAD, et al. Dilution and redistribution effects of rapid 2-litre infusions of 0.9% (w/v) saline and 5% (w/v) dextrose on haematological parameters and serum biochemistry in normal subjects: A double-blind crossover study. Clin Sci 2001;101:173-9.
28. Williams EL, Hildebrand KL, McCormick SA, et al. The effect of intravenous lactated Ringer's solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. Anesth Analg 1999;88:999-1003.
29. Wilcox CS. Regulation of renal blood flow by plasma chloride. J Clin Invest 1983;71:726-35.
30. Waters JH, Bernstein CA. Dilutional acidosis following hetastarch or albumin in healthy volunteers. Anesthesiology 2000;93:1184-7.
31. Lobo DN, Bjarnason K, Field J, et al. Changes in weight, fluid balance and serum albumin in patients referred for nutritional support. Clin Nutr 1999;18:1970-201.
32. Gill MJ, Franch G, Guirao X, et al. Response of severely malnourished patients to preoperative parenteral nutrition: A randomized clinical trial of water and sodium restriction. Nutrition 1997;13:26-31.
33. Starker PM, Lasala PA, Askanazi J, et al. The response to TPN. A form of nutritional assessment. Ann Surg 1983;198:720-4.
34. Lobo DN, Dube MG, Neal KR, et al. Problems with solutions: Drowning in the brine of an inadequate knowledge base. Clin Nutr 2000;20:125-30.
35. Wade CE, Grady JJ, Kranmer GC, et al. Individual patient cohort analysis of the efficacy of hypertonic saline/dextran in patients with traumatic brain injury and hypotension. J Trauma 1997;42:S61-5.
36. Simma B, Burger R, Falk M, et al. A prospective, randomized, and controlled study of fluid management in children with severe head injury: Lactated Ringer's solution versus hypertonic saline. Crit Care Med 1998;26:1265-70.
37. Peterson B, Khanna S, Fisher B, et al. Prolonged hypernatremia controls elevated intracranial pressure in head-injured pediatric patients. Crit Care Med 2000;28:1136-43.
38. Favre JB, Ravussin P, Chiolero R, et al. Hypertonic solutions and intracranial pressure. Schweiz Med Wochenschr 1996;126:1635-43.
39. Cross JS, Gruber DP, Burchard KW, et al. Hypertonic saline fluid therapy following surgery: A prospective study. J Trauma 1989;29:817-25.
40. Vassar MJ, Fischer RP, O'Brien PE, et al. Multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Arch Surg 1993;128:1003-11.
41. Shimazaki S, Yukioka T, Matuda H. Fluid distribution and pulmonary dysfunction following burn shock. J Trauma 1991;31:623-6.
42. Scalia SV, Taheri PA, Force S, et al. Mesenteric microcirculatory changes in nonlethal hemorrhagic shock: The role of resuscitation with balanced electrolyte or hypertonic saline/dextran. J Trauma 1992;33:321-5.
43. Rotstein OD. Novel strategies for immunomodulation after trauma: Revisiting hypertonic saline as a resuscitation strategy for hemorrhagic shock. J Trauma 2000;49:580-3.
44. Corso CO, Okamoto S, Rüttinger D, et al. Hypertonic saline dextran attenuates leukocyte accumulation in the liver after hemorrhagic shock and resuscitation. J Trauma 1999;46:417-23.
45. Murao Y, Hoyt DB, Loomis W, et al. Does the timing of hypertonic saline resuscitation affect its potential to prevent lung damage? Shock 2000;14:18-23.
46. Partrick DA, Moore EE, Offner PJ, et al. Hypertonic saline activates lipid-primed human neutrophils for enhanced elastase release. J Trauma 1998;44:592-7.
47. Ciesla DJ, Moore EE, Zallen G, et al. Hypertonic saline attenuation of polymorphonuclear neutrophil cytotoxicity: Timing is everything. J Trauma 2000;48:388-95.
48. Loomis WH, Namiki S, Hoyt DB, et al. Hypertonicity rescues T cells from suppression by trauma-induced anti-inflammatory mediators. Am J Physiol Cell Physiol 2001;281:C840-8.
49. Junger WG, Hoyt DB, Hamreus M, et al. Hypertonic saline activates protein tyrosine kinases and mitogen-activated protein kinase p38 in T-cells. J Trauma 1997;42:437-43.
50. Thompson WL. Rational use of albumin and plasma substitutes. Johns Hopkins Med J 1975;36:220-5.
51. Baldassarre S, Vincent J-L. Coagulopathy induced by hydroxyethyl starch. Anesth Analg 1997;84:451-3.
52. Boldt J, Heesen M, Welters I, et al. Does the type of volume therapy influence endothelial-related coagulation in the critically ill? Br J Anaesth 1995;75:740-6.
53. Haisch G, Boldt J, Krebs C, et al. Influence of a new hydroxyethyl preparation (HES 130/0.4) on coagulation in cardiac surgery patients. J Cardiothorac Vasc Anesth 2001;15:316-21.
54. Haisch G, Boldt J, Krebs C, et al. The influence of intravascular volume therapy with a new hydroxyethyl strach preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery. Anesth Analg 2001;92:565-71.
55. Traylor RJ, Pearl RG. Crystalloid versus colloid: All colloids are not created equal. Anesth Analg 1996;83:209-12.
56. Oz MC, FitzPatrick MF, Zikria BA, et al. Attenuation of microvascular permeability dysfunction in post-ischemic striated muscle by hydroxyethyl starch. Microvasc Res 1995;50:71-9.
57. Schmand JF, Ayala A, Morrison MH, et al. Effects of hydroxyethyl starch after trauma-hemorrhagic shock: Restoration of macrophage integrity and prevention of increased circulating interleukin-6 levels. Crit Care Med 1995;23:806-14.
58. Hofbauer R, Moser D, Hornykewyez S, et al. Hydroxyethyl starch reduces the chemotaxis of white cells through endothelial cell monolayers. Transfusion 1999;39:289-94.
59. Collis RE, Collins PW, Gutteridge CN, et al. The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation: An in vitro study. Intesive Care Med 1994;20:37-41.
60. Boldt J, Heesen M, Muller M, et al. The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesth Analg 1996;83:254-61.
61. Marik PE, Iglesias J, Maini B. Gastric intramucosal pH changes after volume replacement with hydroxyethyl starch or crystalloid in patients undergoing elective abdominal aortic aneurysm repair. J Crit Care 1997;12:51-5.
62. Boldt J, Mueller M, Menges T, et al. Influence of different volume therapy regimens on regulators of the circulation in the critically ill. Br J Anaesth 1996;77:480-7.
63. Younes RN, Yin KC, Amino CJ, et al. Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolaemia: randomised phase II study in the emergency room. World J Surg 1998;22:2-5.
64. Allison K, Gosling P, Jones S, et al. Hydroxyethyl starch reduces capillary leak compared to gelatine solutions during trauma resuscitation. J Trauma 1999;47:1114-21.
65. Rittoo D, Gosling P, Bonnicci C, et al. Splanchnic oxygenation in patients undergoing abdominal aortic aneurysm repair and volume expansion with eloHAES. Cardiovasc Surg 2002;10:128-33.
66. Rittoo D, Gosling P, Burnley S, et al. Hydroxyethyl starch reduces endothelial activation in infrarenal aneurysm surgery. Br J Surg 2001;88:(suppl 1):013.
67. Rittoo D, Gosling P, Burnley S, et al. Hydroxyethyl starch solution (eloHAES) reduces renal dysfunction in infrarenal aortic surgery. Br J Surg (in press).
68. Boldt J, Heesen M, Padberg W, et al. The influence of volume therapy and pentoxifylline infusion on circulating adhesion molecules in trauma patients. Anaesthesia 1996;51:529-35.
69. Beyer R, Harmening U, Rittmeyer O, et al. Use of modified fluid gelatin and hydroxyethyl starch for colloidal volume replacement in major orthopaedic surgery. Br J Anaesth 1997;78:44-50.
70. Cittanova ML, Leblanc I, Legendre C, et al. Effect of hydroxyethyl starch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996;348:1620-2.
71. Schortgen F, Lacherade J-C, Bruneel F, et al. Effects of hydroxyethyl starch and gelatine on renal function in severe sepsis: A multicentre randomised study. Lancet 2001;357:911-16.
72. Gosling P, Rittoo D, Manji M, et al. Hydroxyethyl starch as a risk factor for acute renal failure in severe sepsis. Lancet 2001;358:581, 582-3.
73. Mythen MG, Webb AR. Perioperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery. Arch Surg 1995;130:423-9.
74. Sinclair S, James S, Singer M. Intraoperative intravascular volume optimisation and length of hospital stay after repair of proximal femoral fracture: Randomised controlled trial. BMJ 1997;315:909-12.